Nucleoside Derivatives of 2,6‐Diaminopurine Antivirals: Base‐Modified Nucleosides with Broad‐Spectrum Antimicrobial Properties

Abstract

The plethora of viral outbreaks experienced in the last decade, together with the widespread distribution of many re‐emerging and newly emerging viruses, emphasize the urgent need for novel broad‐spectrum antivirals as tools for early intervention in case of future epidemics. Non‐natural nucleosides have been at the forefront for the treatment of infectious diseases for many years and still represent one of the most successful classes of antiviral molecules on the market. In the attempt to explore the biologically relevant chemical space of this class of antimicrobials, we describe herein the development of novel base‐modified nucleosides by converting previously identified 2,6‐diaminopurine antivirals into the corresponding D/L ribonucleosides, acyclic nucleosides and prodrug derivatives. A phenotypic screening against viruses belonging to different families (Flaviviridae, Coronaviridae, Retroviridae) and against a panel of Gram‐positive and Gram‐negative bacteria, allowed to identify a few interesting molecules with broad‐spectrum antimicrobial activities.